{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:25:33Z","timestamp":1761823533001},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.taap.2012.11.015","type":"journal-article","created":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T13:32:02Z","timestamp":1354109522000},"page":"375-384","source":"Crossref","is-referenced-by-count":7,"title":["Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats"],"prefix":"10.1016","volume":"266","author":[{"given":"Yunli","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.11.015_bb0230","series-title":"ABI PRISM 7700 Sequence Detection System","article-title":"Relative quantitation of gene expression. User Bulletin #2","author":"Anonymous","year":"1997"},{"key":"10.1016\/j.taap.2012.11.015_bb0005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jdiacomp.2012.03.013","article-title":"Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates \u03b2-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes","volume":"26","author":"Akarte","year":"2012","journal-title":"Diabetes Complicat."},{"key":"10.1016\/j.taap.2012.11.015_bb0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4158\/EP.10.1.40","article-title":"Severe hyperglycemia during gatifloxacin therapy in patients without diabetes","volume":"10","author":"Arce","year":"2004","journal-title":"Endocr. Pract."},{"issue":"Sup3","key":"10.1016\/j.taap.2012.11.015_bb0015","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.2337\/diabetes.53.suppl_3.S205","article-title":"Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo","volume":"53","author":"Baggio","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.taap.2012.11.015_bb0020","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1345\/aph.1A480","article-title":"Possible gatifloxacin-induced hypoglycemia","volume":"36","author":"Baker","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.taap.2012.11.015_bb0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.amjopharm.2005.12.004","article-title":"Hyperglycemia and gatifloxacin: a case report and summary of current literature","volume":"3","author":"Beste","year":"2005","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.taap.2012.11.015_bb0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00256695","article-title":"Rapid chemosensitivity testing of human lung tumor cells using the MTT assay","volume":"17","author":"Cole","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2012.11.015_bb0035","doi-asserted-by":"crossref","first-page":"e3974","DOI":"10.1371\/journal.pone.0003974","article-title":"Bitter taste receptors influence glucose homeostasis","volume":"3","author":"Dotson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2012.11.015_bb0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2012.11.015_bb0045","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2353\/ajpath.2008.080238","article-title":"Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway","volume":"173","author":"Favaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2012.11.015_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1592\/phco.21.1.35.34440","article-title":"Gatifloxacin, an advanced 8-methoxy fluoroquinolone","volume":"21","author":"Fish","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.taap.2012.11.015_bb0055","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1086\/496929","article-title":"Glucose homeostasis abnormalities associated with use of gatifloxacin","volume":"41","author":"Frothingham","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"6 Pt 2","key":"10.1016\/j.taap.2012.11.015_bb0060","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1592\/phco.20.8.49S.35186","article-title":"A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men","volume":"20","author":"Gajjar","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.taap.2012.11.015_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2007.07.038","article-title":"Gatifloxacin affects GLUT1 gene expression and disturbs glucose homeostasis in vitro","volume":"573","author":"Ge","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.11.015_bb0070","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bcp.2008.11.019","article-title":"The insulinotropic effect of fluoroquinolones","volume":"77","author":"Ghaly","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.11.015_bb0075","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/314061","article-title":"Clinical pharmacology of gatifloxacin, a new fluoroquinolone","volume":"31","author":"Grasela","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.taap.2012.11.015_bb0080","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2337\/diabetes.52.5.1147","article-title":"A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line","volume":"52","author":"Gribble","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.taap.2012.11.015_bb0095","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2012.11.015_bb0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/361362a0","article-title":"Pancreatic beta cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7\u201337)","volume":"361","author":"Holz","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.taap.2012.11.015_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10156-006-0429-Z","article-title":"Effect of fluoroquinolones on plasma glucose levels in fasted and glucose-loaded mice","volume":"12","author":"Hori","year":"2006","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.taap.2012.11.015_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2008.03.004","article-title":"Involvement of chronic stresses in rat islet and INS-1 cell glucotoxicity induced by intermittent high glucose","volume":"291","author":"Hou","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.taap.2012.11.015_bb0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2010.07.032","article-title":"Gatifloxacin-induced histamine release and hyperglycemia in rats","volume":"645","author":"Ishiwata","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.11.015_bb0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1248\/bpb.29.527","article-title":"Effects of gatifloxacin on serum glucose concentration in normal and diabetic rats","volume":"29","author":"Ishiwata","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2012.11.015_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4093\/kdj.2010.34.1.47","article-title":"The effect of glucose fluctuation on apoptosis and function of INS-1 pancreatic beta cells","volume":"34","author":"Kim","year":"2010","journal-title":"Korean Diabetes J."},{"key":"10.1016\/j.taap.2012.11.015_bb0115","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.2337\/db06-S020","article-title":"Glucagon-like peptide 1 secretion by the L-cell the view from within","volume":"55","author":"Lim","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.taap.2012.11.015_bb0120","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.bcp.2008.01.004","article-title":"Insulin therapy restores impaired function and expression of P-glycoprotein in blood\u2013brain barrier of experimental diabetes","volume":"75","author":"Liu","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.11.015_bb0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1292\/jvms.09-0465","article-title":"Clinicopathological aspect of dysglycemia in naive and diabetic rats induced by the fluoroquinolone antibacterial gatifloxacin","volume":"72","author":"Nagai","year":"2010","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.taap.2012.11.015_bb0135","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-06-0756","article-title":"Co-localisation of the Kir6.2\/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes","volume":"156","author":"Nielsen","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.taap.2012.11.015_bb0140","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0025-7125(05)70297-2","article-title":"Clinical use of the fluoroquinolones","volume":"84","author":"Owens","year":"2000","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.taap.2012.11.015_bb0145","first-page":"604989","article-title":"Subthreshold \u03b12-adrenergic activation counteracts glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion","volume":"2011","author":"Pan","year":"2011","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.taap.2012.11.015_bb0150","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00125-012-2585-2","article-title":"Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion","volume":"55","author":"Parker","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.taap.2012.11.015_bb0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/meta.2001.22519","article-title":"Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro","volume":"50","author":"Parkes","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.taap.2012.11.015_bb0160","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jcp.2006.043232","article-title":"Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1","volume":"61","author":"Ranganath","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.taap.2012.11.015_bb0165","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.2337\/diabetes.51.9.2757","article-title":"Glucose-sensing in glucagon-like peptide-1-secreting cells","volume":"51","author":"Reimann","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.taap.2012.11.015_bb0170","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cmet.2008.11.002","article-title":"Glucose sensing in L cells: a primary cell study","volume":"8","author":"Reimann","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.taap.2012.11.015_bb0175","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/en.142.10.4522","article-title":"A human cellular model for studying the regulation of glucagon-like peptide-1 secretion","volume":"142","author":"Reimer","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.taap.2012.11.015_bb0180","doi-asserted-by":"crossref","first-page":"26488","DOI":"10.1074\/jbc.270.44.26488","article-title":"Differential processing of proglucagon by the subtillisin-like prohormone convertase PC2 and PC3 to generate either glucagon or glucagon-like peptide","volume":"270","author":"Rouille","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.11.015_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2004.06.032","article-title":"Effects of fluoroquinolones on insulin secretion and -cell ATP-sensitive K+ channels","volume":"497","author":"Saraya","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.11.015_bb0190","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.2146\/ajhp050119","article-title":"Development of diabetes after gatifloxacin therapy","volume":"62","author":"Stading","year":"2005","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.taap.2012.11.015_bb0195","first-page":"521","article-title":"Analysis of patients with hypoglycemia and\/or hyperglycemia induced by gatifloxacin. Risk factors and patient profiles","volume":"52","author":"Tamayama","year":"2004","journal-title":"Jpn. J. Chemother."},{"key":"10.1016\/j.taap.2012.11.015_bb0200","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1248\/bpb.30.644","article-title":"Gatifloxacin induces augmented insulin release and intracellular insulin depletion of pancreatic islet cells","volume":"30","author":"Tomita","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2012.11.015_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2006.09.043","article-title":"Gatifloxacin acutely stimulates insulin secretion and chronically suppresses insulin biosynthesis","volume":"553","author":"Yamada","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.11.015_bb0215","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jep.2009.05.027","article-title":"Huang-Lian-Jie-Du decoction modulates glucagon-like peptide 1 secretion in diabetic rats","volume":"124","author":"Yu","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2012.11.015_bb0210","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.bcp.2009.11.017","article-title":"Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies","volume":"79","author":"Yu","year":"2010","journal-title":"Biochem. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12004966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12004966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T23:54:36Z","timestamp":1540079676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12004966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0041008X12004966"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.11.015","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}